Yoginii partners with Panacea Biotec to expand wellness portfolio

Collaboration brings Staart Prime, ChilRun and NikoMom products to Yoginii’s platform, strengthening its family-focused wellness ecosystem and supporting women through motherhood and family care

Takeda promotes Garima Srivastava as VP HR, Global Head of Talent Acquisition for Commercial

Seasoned HR leader brings over 15 years of experience in global talent strategy, organizational transformation, and workforce planning

Samsung Bioepis launches Aflibercept biosimilar OPUVIZ across Europe

The aflibercept biosimilar, referencing Eylea, becomes the company’s fifth directly commercialized biosimilar in Europe, expanding access to ophthalmology treatments

Clariant bags FDA nod for bio-based PVC additives

Derived from rice bran wax, Licocare RBW products offer a renewable solution with a substantially lower carbon footprint than conventional montan waxes

Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections

The approval marks a major milestone in the global fight against antimicrobial resistance

Pfizer and FITT IIT Delhi identify 20 health startups under innovation programme

Selected ventures to receive grants and structured intellectual property support to strengthen protection and management of healthcare innovations

Lupin wins FDA nod for generic colonoscopy prep drug with first-to-file exclusivity

Crucially, Lupin is the exclusive first-to-file applicant for this product and is eligible for 180-day generic drug exclusivity in the U.S. market

Glenmark posts strong FY26 results with 27.5% revenue jump

FDA delays AstraZeneca decision on camizestrant as regulators seek more data

The filing is backed by results from the pivotal SERENA-6 Phase III trial

Lupin secures FDA nod for generic Sutab tablets with 180-day exclusivity

The approved product is the generic equivalent of Sutab® Tablets developed by Azurity Pharmaceuticals